Tango Therapeutics Earnings
NASDAQ: TNGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.34
Tango Therapeutics earnings summary
Tango Therapeutics is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.34. In its most recent report on Aug 11, 2026 (Q2 2026), TNGX posted EPS of $-0.37. Revenue for the quarter was $0.
Across the last 16 reports, TNGX shares moved an average of 8.2% (in either direction) in the first trading session after results, rising 11 times and falling 5 times.
Summary generated from market data by MetaCap's automated system. Methodology
TNGX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 11, 2026 | — | $-0.37 | — | -6.7% |
| May 13, 2026 | — | $-0.32 | — | -1.6% |
| Mar 5, 2026 | — | $-0.29 | — | +2.1% |
| Nov 4, 2025 | — | $0.13 | — | +3.8% |
| Aug 5, 2025 | — | $-0.35 | — | +2.4% |
| May 12, 2025 | — | $-0.36 | — | +22.7% |
| Feb 27, 2025 | — | $-0.33 | — | -2.9% |
| Nov 6, 2024 | — | $-0.27 | — | +30.5% |
| Aug 7, 2024 | — | $-0.24 | — | +17.2% |
| May 8, 2024 | — | $-0.35 | — | +5.8% |
| Mar 18, 2024 | — | $-0.30 | — | +2.7% |
| Nov 8, 2023 | — | $-0.23 | — | -9.1% |
| Aug 7, 2023 | — | $-0.23 | — | -7.6% |
| May 9, 2023 | — | $-0.32 | — | +3.6% |
| Mar 27, 2023 | — | $-0.33 | — | +12.2% |
| Nov 10, 2022 | — | $-0.33 | — | +1.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.